| 000 | 01839 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513123810.0 | ||
| 264 | 0 | _c19971001 | |
| 008 | 199710s 0 0 eng d | ||
| 022 | _a0006-8993 | ||
| 024 | 7 |
_a10.1016/s0006-8993(97)00348-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarth, A | |
| 245 | 0 | 0 |
_aNeurotoxicity in organotypic hippocampal slices mediated by adenosine analogues and nitric oxide. _h[electronic resource] |
| 260 |
_bBrain research _cJul 1997 |
||
| 300 |
_a79-88 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_a2-Chloroadenosine _xpharmacology |
| 650 | 0 | 4 |
_aAdenine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAdenosine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAdenosine Deaminase Inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAnimals, Newborn |
| 650 | 0 | 4 |
_aBrain Ischemia _xmetabolism |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aHippocampus _xblood supply |
| 650 | 0 | 4 |
_aNeurons _xchemistry |
| 650 | 0 | 4 |
_aNeurotoxins _xpharmacology |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 | _aOrgan Culture Techniques |
| 650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Purinergic P1 _xmetabolism |
| 650 | 0 | 4 |
_aTheobromine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aTheophylline _xpharmacology |
| 650 | 0 | 4 |
_aXanthines _xpharmacology |
| 700 | 1 | _aNewell, D W | |
| 700 | 1 | _aNguyen, L B | |
| 700 | 1 | _aWinn, H R | |
| 700 | 1 | _aWender, R | |
| 700 | 1 | _aMeno, J R | |
| 700 | 1 | _aJanigro, D | |
| 773 | 0 |
_tBrain research _gvol. 762 _gno. 1-2 _gp. 79-88 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0006-8993(97)00348-x _zAvailable from publisher's website |
| 999 |
_c9241779 _d9241779 |
||